martes, 31 de mayo de 2022

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial - The Lancet Respiratory Medicine

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario